FIGS Q2 2025 Earnings Call Transcript

Quartr
Provided by Quartr
August 7, 2025

Key Takeaways

  • Positive Sentiment: Record Q2 revenue growth of 6% and scrubwear up 8%, driven by enhanced product merchandising and strong ecommerce performance.
  • Positive Sentiment: Adjusted EBITDA margin climbed 390 bps year-over-year to 12.9% on logistics efficiencies and disciplined expense controls.
  • Positive Sentiment: Raised fiscal 2025 guidance to low single-digit revenue growth and an EBITDA margin range of 8.5–9%, reflecting top-line momentum and cost mitigation.
  • Neutral Sentiment: Expecting a ~150 bps tariff headwind in 2025, with mitigation via diversified sourcing, supplier negotiations and operational savings—pricing remains a last resort.
  • Positive Sentiment: Accelerating global footprint with a launch in Japan, planned entry into South Korea and three new community hubs opening in Houston, New York City and Chicago.
AI Generated. May Contain Errors.
Earnings Conference Call
FIGS Q2 2025
00:00 / 00:00

Transcript Sections

Skip to Participants
Operator

Good afternoon. Thank you for attending the FIG's Second Quarter Fiscal twenty twenty five Earnings Conference Call. My name is Cameron, and I'll be your moderator for today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. And I would now like to pass the conference over to your host, SVP of Investor Relations, Tom Shaw. You may proceed.

Tom Shaw
Tom Shaw
SVP of Investor Relations at FIGS

Good afternoon and thank you for joining us to discuss FIG's second quarter twenty twenty five results, which we released this afternoon and can be found in our earnings press release and in the shareholder presentation posted to our Investor Relations website at ir.wherefigs.com. Presenting on today's call are Trina Speer, our Co Founder and Chief Executive Officer and Sarah Altred, our Chief Financial Officer. As a reminder, remarks in this call that do not concern past events are forward looking statements. These may include predictions, expectations or estimates, including about future financial performance, market opportunity or business plans. Forward looking statements involve risks and uncertainties and actual results could differ materially.

Tom Shaw
Tom Shaw
SVP of Investor Relations at FIGS

These and other risks are discussed in our SEC filings, including in the 10 Q we filed today. Do not place undue reliance on forward looking statements, which speak only as of today and which we undertake no obligation to update. Finally, we will discuss certain non GAAP metrics and key performance indicators, which we believe are useful supplemental measures for understanding our business. Definitions and reconciliations of these non GAAP measures to the most comparable GAAP measures are included in the shareholder presentation we issued today. And now I'd like to turn the call over to Trina.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Thanks, Tom, and good afternoon, everyone. Following our strong top line performance in q one, we were encouraged to see momentum continue in the second quarter, where solid execution drove our largest revenue quarter in our history and powered overall results ahead of expectations. We placed the health care community at the center of all we do, and this unrelenting focus is coming through across three highly successful and interrelated areas. First, we have strengthened our product merchandising efforts through clear assortment architecture, strategic newness, and continued improvements in fit and function. Second, we have created some of our most impactful marketing to date that has resonated broadly across the health care community and driven deeper engagement.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And third, we have strategically repositioned the business away from broader based promotional periods, driving more productivity and intentionality to our overall business. This high level of execution is generating success in the foundational parts of our business, including The United States, our ecommerce channel, and within core scrub wear. We also believe these successful efforts are being amplified as we move further past the COVID overhang towards a more normalized purchasing and replenishment backdrop. Looking at q two, net revenues outpaced expectations with 6% growth supported by several high quality measures that build our confidence for the balance of the year. From a category perspective, our scrubwear posted an 8% gain, which was the highest growth in the past seven quarters.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

This is a great example of where integrated merchandising efforts are coming through, and we are energized by what we are seeing here as our collective efforts across newness, fabric, color, and fit continue to come together in the seasons ahead. From a customer perspective, growth in our active customers was supported by solid gains in both acquisition and returning customers. We also saw strong trends in two important measures that we believe are indicative of growing brand health. First, AOB gained 4% to come in just below our record level achieved last quarter. Second, customers responded particularly strongly during our baseline days with pronounced growth during these periods that more than offset our planned reductions to our promotional days.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

As a reminder, we are continuing to be more deliberate with how and when we use promotions throughout 2025. Finally, from a geographic perspective, our US business was positive for the second straight quarter, growing on top of the modest gain in q two last year. And as I'll discuss shortly, the international business continues to mix higher as we drive investment and impact to more markets. Magnifying our top line momentum, margins were also better than planned. In particular, our team has done a fantastic job of aggressively working to right size our logistics footprint and drive efficiencies.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

While these gains materialized quicker than expected, they are ones that we intend to sustain and build off of going forward. Even as we kept our focus on strategic investments in other parts of our p and l, our adjusted EBITDA margin improved 390 basis points year over year to 12.9%, which we believe demonstrates the power of our model when top line gains are matched with disciplined expense management. Looking ahead, we believe we're in a great position to both leverage our first half demand momentum and may and manage what remains a very dynamic trade environment. Given tariff uncertainty, our team had a productive trip during q two to visit a number of our key suppliers where we focused on fortifying our strong relationships, building flexibility in our footprint, and driving future innovation and development. Stigs remains an important sought after partner for suppliers supported by the nonseasonal replenishment nature of our assortment.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Sarah will detail our outlook inclusive of last week's trade updates. But even with the current tariff assumptions, we believe our revenue strength and early cost mitigation efforts position us favorably from our call three months ago. Overall, this means an improved outlook with fiscal twenty twenty five top line now expected to grow low single digits and an increased adjusted EBITDA margin range to eight and a half to 9%. To be clear, there's more work to be done here as we plan for tariff impacts in 2026, but are encouraged by the mitigation options in our toolkit as we look across supplier negotiations, ongoing s g and a savings, and focused pricing action. Now shifting back to our strategy, where serving health care professionals remains at the heart of all we do.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We continue to focus on what impact we can have on our community and how we can best celebrate them. We believe these are the key measures to differentiate the brand with health care professionals and ultimately drive the value of our company to all stakeholders. To that end, we're incredibly proud of our recent efforts. On our last earnings call, we were right in the middle of nurses week, which went on to become one of our most comprehensive and impactful effort for the celebration to date. We hosted 18 events across the country, capped the week with a feature on the Jennifer Hudson show, and unveiled a powerful new chapter of our Where Do You Wear Pigs campaign, a rallying cry to uplift nurses and spotlight the impact they make every day.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

The response was extraordinary. Figs had approximately 900,000,000 impressions, easily attaining the largest nurses week reach in our history. Film views were up an incredible 10 x year over year, and overall social engagement was up five x. As with all brand building efforts, we expect the full impact to compound over time, but we believe the extraordinary engagement we're seeing is already fueling growth in our business, and we're not slowing down. Just this week, we launched the fourth chapter of Where Do You Wear Figs, filmed at the University of Wisconsin, the alma mater of our cofounder, Heather Hasson.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

This chapter puts the spotlight on students, their real challenges, and their aspirations as they pursue a career in medicine. It's also the cornerstone of our back to school campaign, which importantly returned to its regular cadence this year. We're excited to carry this momentum into the second half of the year with more chapters to come, all rooted in our mission to celebrate, empower, and serve our community in meaningful ways. As we think about furthering our impact, we set a new bar for ourselves when we headed to Washington DC in June with 18 extraordinary FIGS ambassadors for awesome humans on the hill. This event is a capstone to our on the ground efforts in DC throughout the year to advocate for solutions to the biggest policy challenges facing health care professionals.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And this year, we went bigger than ever. During this year's Awesome Humans on the Hill, we focused our efforts on three key issues from our policy platform. To ease financial strain, we lobbied for the awesome humans act developed by figs to provide a tax credit for health care professionals. To protect mental health, we urge the reauthorization and funding of the doctor Lorna Breen health care provider protection act. And to alleviate administrative burdens and return the focus to patients, we advocated for the reducing medically unnecessary delays in care act, legislation that would make much needed improvements to the broken prior authorization system.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We brought our advocacy efforts directly to both the biggest powers in congress and all Americans with the support of actor and health care advocate, Noah Wiley, from the pit and ER, and even more importantly, his mother, Marty Wiley, an orthopedic nurse of nearly fifty years. Recently nominated for Emmys for best drama and best actor for Noah, the pit has served as Noah's love letter to frontline health care workers and highlights the same challenges we have been working so hard to address with our advocacy. Together with no one or a team of ambassadors, we had over 35 meetings with policymakers from both sides of the aisle and held a congressional briefing to a packed room in the capital. We also had live segments on CBC Mornings and ABC News, a powerful op ed in USA Today, and captured over 5,000,000 organic views from our social posts alone. Bottom line, there's no health care without a well cared for health care workforce, And it's our privilege and our responsibility to ensure that lawmakers keep this top of mind as they craft health care policy.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Moving to our international strategy where we drove impressive gains across Mexico, Europe, Latin America, and The Middle East. Similar to last quarter, we saw some softness in Canada, largely given an outsized impact of our promotional pullback. However, we were encouraged with positive performance during our full price periods in this market and have continued to take localized action to spur demand. Our overall international approach this year has centered around investing and execution. A key milestone in q two was the debut of our business in Japan, where we are off to a good start.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Our main focus is to continue to listen and learn from our community and apply localized strategies to drive awareness. Next up in q three, we are adding another important country to our roster with the planned launch of South Korea. We are taking a similarly measured approach there, learning cultural nuances and preferences. We are excited to take these two big steps as we start to expand our business across the Asia Pacific region and look forward to seeing the impact on our business in 2026 and beyond. As we indicated last quarter, we are also harnessing technology to expand our regional approach to new markets.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

This strategy focuses on leveraging regional commonalities like purchase behaviors, language, and seasonality, allowing us to accelerate our entry into additional markets while retaining a premium brand positioning. Just last week, we utilized this program in Latin America to open 12 new markets across the region. Finally, we are in the early process of investing resources in market across our business function. We will have more to come on this front over time as we focus our initial efforts on Canada, The UK, and Mexico. Our investment focus this year extends our team's business, where we continue to see immense opportunities to reach new global health care institutions over time.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

To truly scale this opportunity, we are hyper focused on several areas this year. This starts with adding talent and driving sharper focus in how we build relationships across a diverse range of health care institutions. We then support these efforts by expanding our work on the technology side, supporting flexible customer solutions and a streamlined user experience. Finally, we're building out our marketing engine to support the overall awareness of this business. Importantly, we continue to believe these teams' efforts will have added importance as we look outside The US where there are different buying nuances and preferences.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Community hubs also remains an exciting opportunity to extend our engagement with new and existing health care professionals. As we outlined last quarter, the channel continues to see about 40% of customers coming in new to the brand, and approximately 30% of these acquired customers go on to purchase through our ecommerce channel. We are also capturing unique insights in the channel. For example, during the second quarter, this included a stronger core scrub wear mix, stronger men's penetration, the higher adoption of our FormX fabrication, and the ongoing success of embroidery. Our ability to bring the brand to locations that add convenience to the busy lives of health care professionals also makes community hubs appealing.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Last quarter, we highlighted our next hub is in Houston, which is opening within steps of the world's largest medical complex. We are also excited to announce that we're working toward planned openings of our next two hubs in New York City and Chicago. Opening the Upper East Side, the New York location combines a densely populated residential area, strong existing ecommerce demand, and a high concentration of premium health care institutions. This includes Memorial Sloan Kettering, New York Presbyterian, Weill Cornell, and Lenox Hill. Our Chicago location will open near the Illinois Medical District, one of the largest in North America.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

With planned store sizes ranging between our existing two locations, we are excited to take early learnings and apply an updated design to these three new openings. Before handing the call over to Sarah, I wanna reiterate our growing confidence in the momentum of our business and our excitement in the opportunities we see ahead. We are managing macro uncertainty well, executing in the areas we can control, and setting ourselves up for continued success. We are supported by an incredibly strong balance sheet, which allows us to make thoughtful strategic decisions in how we invest today and also return value to shareholders over the long term. And most importantly, we are proud of how our unrelenting focus and leadership in the health care space supports this amazing community. With that, I'll pass it over to Sarah.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Thanks, Trina. FIG's strong second quarter results were above expectations on both top and bottom line, highlighting the ongoing momentum of our efforts with product, marketing, and promotional repositioning and demonstrating the successful execution of some of our targeted expense measures. Net revenues increased 6% year over year to a $152,600,000 above our outlook of approximately flat performance for the period. We were particularly encouraged by strength in some of the core elements of our business, including improved trends in our overall scrub wear category across core colors and styles, strong growth in our business as usual selling periods, and the overall growth in our domestic business as we reached a new quarterly sales record in The US. As planned, we also continue to execute on a more intentional pullback with our promotional strategy in 2025.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

While this create headwinds year over year, we believe this sets us up for long term success, and we are pleased to see more productivity during this year's more limited offerings. Looking further at our trends, AOV increased 4% to a $117, primarily driven by higher average unit retail due to product mix and lower return rates. On the customer front, while we continue to see some impact from our promotional changes this year, we were excited to see improving acquisition trends and the ongoing success of reengaging returning customers. Overall, our active customers increased 4% year over year to 2,700,000, while net revenues per active customer eased less than one percent to $208. By category, scrub wear grew 8%, representing 83% of net revenues for the period and exceeding our expectations.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

As Trina mentioned, we have been effective across our product merchandising efforts, driving momentum to our core and supporting productive new colors and style launches. We also progressed on our fit efforts with key styles starting to be fully updated during nurses week. Non scrub wear decreased 3%, representing 17% of net revenues. The category overall had a higher negative impact from the pullback in our promotional strategy. Additionally, our intentional shift in the marketing calendar and overall campaign focus put more of the product spotlight on our core scrubwear business during the period.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

By geography, US sales increased 4% to a $129,900,000, our strongest performance in nearly two years and supported by balanced growth from both new and repeat customers. International net revenues increased 20% with many of the same dynamics seen in The US playing out globally, just at a higher rate. This includes strong new and existing customer growth and great performance during our baseline days. Gross margin for Q2 contracted 40 basis points to 67%, though continuing to trend in a fairly tight range over the past year. Results were impacted by higher inventory reserves and a modest impact from higher tariffs and were partially offset by a higher duty drawback and a lower return rate.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Our selling expense for q two was $34,400,000 representing 22.6% of net revenues compared to 25.6% last year. We were proud of our efforts here with several of our efficiency and mitigation strategies across both fulfillment and shipping taking hold quicker than expected. On the fulfillment side, we are driving continuous improvements across the board as we work to optimize operations and align costs at this much larger distribution center. While outbound shipping had been a headwind, we took swift action to optimize our carrier mix and pricing, driving significant savings without sacrificing service. Marketing expense for q two was $23,200,000 representing 15.2% of net revenues, down from 15.9% last year and generally in line with expectations.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

G and A for Q2 was 34,700,000 representing 22.8% of net revenues compared to 24.8% last year. Similar to last quarter, the Q2 decrease in the G and A expense rate was due to meaningfully lower stock based compensation expense. This impact was partially offset by higher people costs as we invest in scaling the business as well as higher depreciation related to asset purchases for the fulfillment center. In total, our adjusted EBITDA for Q2 was $19,700,000 with an adjusted EBITDA margin of 12.9% compared to nine percent last year. Net income for the quarter was $7,100,000 or diluted EPS of $04 compared to net income of $1,100,000 last year or diluted EPS of $01 Onto our balance sheet, we finished the second quarter with a strong net cash, cash equivalents and short term investment position of $238,800,000 Inventory increased 14% year over year to a $135,500,000 or up 8% on a unit basis.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

The delta between dollar growth and unit growth during the quarter reflects the impact of higher average unit pricing due to product mix and some modest tariff impact. For the balance of the year, we currently expect unit growth to continue to outpace revenue growth given planned product introductions and deeper investments in select areas of the business. We also expect total inventory growth will accelerate the next two quarters, widening the gap with unit growth as higher tariff goods are brought in. On the capital allocation side, we did not repurchase shares this period and have $52,000,000 available for future repurchases under our current share repurchase program. In the near term, we plan to focus on prioritizing investments in our business and preserving our balance sheet strength as trade dynamics stabilize.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Capital expenditures for the quarter were $1,100,000 and we now expect approximately $6,000,000 for the full year. Now turning to our outlook for the balance of the year. While the tariff backdrop continues to evolve, our year to date execution and effective strategic planning are supporting higher top and bottom line outlooks from what we outlined three months ago. Embedded in this outlook, we continue to expect an unmitigated tariff impact of approximately a 150 basis points, though I'll cover how the assumptions in this estimate have evolved. Considering the net impact of several factors, including an improved top line, successful mitigation initiatives and ongoing investments, we are now pleased to be back within 50 basis points of our original 2025 outlook.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Looking at the specifics, full year 2025 net revenues are now expected to grow low single digits year over year, improving from our prior outlook of down low single digits. This updated range includes the outperformance from our q two results as well as added confidence in our second half assumptions. As we have outlined today, we have been successful in reinvigorating our customer funnel and accelerating growth across core elements of our business, which we believe will better support back half of the year trends. However, we continue to factor in two dynamics that are expected to limit our second half performance. First, we expect a greater headwind from our ongoing promotional changes with more aggressive reductions of promotional days planned in q three and q four.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Second, we continue to factor in some uncertainty around macro consumer behavior, particularly as trade policies continue to unfold and the consumer faces a range of potential pricing impacts across purchase decisions. Looking specifically at the third quarter, we are planning for net revenues in a range of flat to up 2% growth year over year. Onto gross margins, where we expect approximately a 150 basis points of total pressure for the year, which corresponds with the expected tariff headwind. As it relates to our current tariff positioning, we have worked to evolve our supplier footprint with production now balanced between Vietnam and Jordan while further limiting what was already very limited production in China. With this mix, we are currently planning for added tariffs of 20% in Vietnam, 15% in Jordan and 30% in China.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

While the weighted average impact of these assumptions results in a larger annualized headwind than previously expected, the net incremental impact to 2025 is minimal. This is due to both the earlier favorability in China assumptions and also the later effective dates in Vietnam and Jordan. With average costing and sell through assumptions, the tariff impact is expected to build in Q3 and then again in Q4. Notably, the Q3 tariff headwind is planned to be largely offset by the benefits of our promotional repositioning as well as additional cost mitigation efforts, resulting in an overall gross margin contraction of approximately 50 basis points. However, the growing Q4 tariff pressure, coupled with lapping a sizable onetime benefit from duty drawback claims, creates a meaningfully higher margin drag planned that quarter.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

While the planned tariff pressure will build into 2026, we have a number of levers across supplier negotiations, expense savings and targeted pricing that we will look to deploy next year. In SG and A, we expect a number of sizable expense rate moves over the next two quarters given the timing of comparisons of certain investments as well as from our mitigation strategies. Last year, selling expenses reflected higher fulfillment center expenses, including significant transitory costs in q three, followed by higher than expected operating costs in q four. As we lap the transitory portion of these costs this quarter, our scaling efforts and mitigation strategies are also driving savings and expect the overall selling rate to make meaningful progress in returning closer to 2022 and 2023 levels. The marketing expense rate is expected to be down slightly for the full year, primarily given the Olympics comparison, which would drive sizable expense leverage this q three.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

We note a meaningfully higher rate spend now planned in q four, partially given the lower investment rate in the prior year's period, but also to ramp up investments ahead of the twenty twenty six Winter Olympics, which begins in early February. G and A expenses will continue to reflect higher planned people costs, which will be more than offset by what is now planned to be a 14,500,000 reduction in stock based comp year over year. As we look at full year adjusted EBITDA margin, which includes the impact of stock based compensation expense, we now expect a range of 8.5% to 9% ahead of our prior outlook of 7.5 to 8.5%. For Q3, we expect an adjusted EBITDA margin of 9% to 9.5%, up significantly from 3.4% last year given the discrete investment during that period. This also means a sharply lower planned Q4 margin given the ramping impacts of tariffs and our marketing timing.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Overall, I would like to reiterate how excited we are to see our health care customers respond so well within this environment. We've built a powerful leadership position within the health care apparel space and are now driving even more impactful and expanded engagement across product, channel, and geographies. At the same time, our team has quickly responded in this challenging trade environment, executing a range of cost savings opportunities while also ensuring dollars are deployed to support the long term opportunity. We look forward to building on this execution in the quarters ahead. I will now turn the call back over to the operator for Q and A. Operator?

Operator

Thank you. We will now begin the question and answer session. The first question is from the line of Adrian with Barclays. You may proceed.

Angus Kelleher-Ferguson
Equity Research Associate at Barclays Corporate & Investment Bank

Hi, this is Angus Kelleher on for Adrian Yee. Thanks for taking our question. I wanted to ask about AOV and product innovation impact. So AOV increased 4% in Q2 and has shown steady improvement over recent quarters. Can you rank order the drivers of this recovery in terms of how much is promotional strategy, product mix or new product launches?

Angus Kelleher-Ferguson
Equity Research Associate at Barclays Corporate & Investment Bank

And then on that note, what's your outlook for AOV progression for the rest of 2025? Thank you.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

I can start and then Sarah, if you want to jump in. Thank you, Angus, for the question. Know, I think it's important when you think about AOB, which are it was our second best quarter. We hit a $117, up 4%. But when you think about product innovation, this isn't really a function not only of being, you know, the most what we believe to be the most innovative company in the space.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

It's also a function of being a uniform company. And so a lot of what's driven our success is that, you know, health care professionals are coming to figs for their uniforms, and then they're coming back to us over and over. They're buying our newness or buying our our limited edition products. And then in addition, they're replenishing their core, scrub wearing. So that's a really great dynamic.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

You know, in in that a a AOB, you're seeing a lot of people kind of engaging with higher priced products. So that's an a AUR is really driving that, and that's also really exciting to see. In terms of ranking, you know, the the the, you know, the pieces of AOV, if Sarah, if you wanna jump in on that.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Sure. So the most favorable impact came from product mix shift, and then we also had some favorability in returns.

Angus Kelleher-Ferguson
Equity Research Associate at Barclays Corporate & Investment Bank

Great. Thank you. That's it for me.

Operator

The next question is from the line of Dana Telsey with Telsey Group. You may proceed.

Dana Telsey
CEO & Chief Research Officer at Telsey Advisory Group

Hi, good afternoon everyone and congratulations on the nice progress. As you think about the engagement you've had with the customer and certainly we're seeing it now in some of the metrics that you mentioned Trina with the active customers, both new and existing. How are you thinking about the newness go forward and the pricing given the tariffs coming in with the normalization that's returning to the healthcare professionals and their buying habits? How are you planning for pricing? Is part of it the tariffs?

Dana Telsey
CEO & Chief Research Officer at Telsey Advisory Group

Is part of it the innovation that you're delivering? How should we think about the go forward? Thank you.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Sure. I can start. Dana, thank you for the question. You know, I think when you think about our success, it's really a result of a lot of the execution that we've been discussing over a long period of time, and we're now seeing the results of our efforts. That execution can be seen across the business, and it really starts with and you mentioned it, product.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

It starts with product, and marketing. Those are our two north stars. And we've made significant investments in these areas, and we're starting to see that investment pay off. So on the product side, you know, we're delivering the best products that meet the needs of our health care professionals. Like I was saying, the the core, is really resonating and continues to resonate.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We've made steady improvements on fit. We continue to, you know, be on our journey on fit, and it's it's we're seeing a lot of great feedback, as well as function. And, you know, that's what we're known for, being the highest quality, most comfortable, medical apparel in the world. And on top of that, we're kind of you know, we have really delivered a very clear assortment architecture that enables us to be strategic, when it comes to newness and when it comes to color drops and style drops across categories. So that's been really exciting to see.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And then on the marketing side, we're really combining, what we're doing as it relates to storytelling around products and around, and around our awesome humans and kinda combining that with the product and seeing incredible success. Sarah, do you wanna talk about the price oh oh, in terms of the pricing, I think, you know, we talked last quarter about, you know, pricing is is kind of our last resort in terms of how to offset tariffs. It's something we've been extremely thoughtful about. And as you know, Dana, health care professionals need our products, to do the work that that they do, and nearly two thirds of our customers make under a $100,000 a year. Additionally, 80% of our product is core.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

So we need to be really mindful when we're thinking about pricing changes. And so as a result, we think we really do feel the right thing to do is use every other tool in our toolkit to mitigate the cost pressure before increasing prices. So what are we looking to do? Number one, we're optimizing our sourcing mix. We have a number of suppliers across regions, and we're really able to take advantage of more favorable tariff rates in different parts of the world.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We are secondly, we're negotiating, with our suppliers and with our manufacturing partners. And we've made a lot of progress here, and there's more work to do, but we feel, good about the conversations we've had. Third, we are optimizing both our inbound and outbound freight. And finally, we're looking across the p and l and finding efficiency within g and a, as once again, you know, pricing is is something that, you know, is is comes after exhausting all these other areas. And any action that we do do in terms of pricing, we're really gonna be mindful of a number of principles.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

You know, we need to be affordable That is what we are known for. We are committed to having the absolute best products at prices that we believe are affordable and accessible for health care professionals. Our pricing will be targeted. We will look to be targeted across products, across categories where we believe we have pricing power.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And finally, we're going to be very mindful around pricing unit impacts and, thinking about, you know, elasticity, of demand. Sarah, don't know if you have anything to add. Okay. I think that's it. Thank you so much, Dana.

Dana Telsey
CEO & Chief Research Officer at Telsey Advisory Group

Thank you.

Operator

The next question is from the line of Brooke Roche with Goldman Sachs. You may proceed.

Brooke Roach
Brooke Roach
VP - Equity Research at Goldman Sachs

Good afternoon and thank you for taking our question. I have a follow-up to that last question on tariffs. Sarah, could you quantify the annualized impact from tariffs that you expect both on a mitigated and unmitigated basis? It sounds like pricing will be very strategic, but will that pricing be a global price increase or a local price increase? And when are you thinking about contemplating implementation of that price? Thank you.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Thanks, Brooke. Yeah. So we've shared that our tariff impact for 2025 is gonna be a 150 basis points, and that's, based on the rates that are in effect today. So 20% for Vietnam, 15% for Jordan, and 30% for China. That is consistent with what we had shared last time, but there have been some movement within that.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

So we did see, the reduction in China rate. So even on a very small mix, it's had some positive impact. And then while the rates for Vietnam and Jordan are higher than what we had guided to previously, the later effective date limits the incremental impact. And we've also continued to optimize our sourcing mix. And then how you can think about the phasing of that, we continue to expect the basis point impact of tariffs to grow progressively throughout the year, and we haven't shared what that impact will be for 2026.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

I think something for you to consider is that the vast majority of our COGS is subject to tariffs, and 85 of our sales are to The US. So I think with that, you can probably come up and drive what a reasonable range of annualized impact would be, and we're actively in the work to mitigate that. Trina shared some of those mitigating actions and shared our pricing philosophy. So at this point, our guidance for 2025 does not reflect any pricing impact. We're gonna continue to work on our mitigation strategies.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And as Trina said, we will wait and really consider the right time for any particular pricing.

Brooke Roach
Brooke Roach
VP - Equity Research at Goldman Sachs

Great. Thanks so much. I'll pass it on.

Operator

The next question is from the line of John Kernan with T. Bowen. You may proceed.

John Kernan
Managing Director at TD Cowen

Good afternoon. Congrats on a nice quarter. I got one for Trina and one for Sarah. Trina, just within the guidance for revenue, it seems like there's a decel implied in both average order value. You addressed some of those points earlier.

John Kernan
Managing Director at TD Cowen

But how should we think about active customers in the back half of the year? It seems like you're pretty excited about some of the engagement you've had with existing customers acquisitions. So just trying to think how we should model that going into the back half.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

I can take that one. Yeah. So we've guided to revenue of zero to 2% in q three. And then, you know, depending that gives you a range of where we would be at for for q four, with our low single digit guide for the year. And so while we've seen great progress in a lot of our metrics, keep in mind that the second half of the year will have the largest impact from our pullback in promo.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

So that will have some impact on our trends in terms of customer acquisition and in terms of our order value as well. So you can see that you know, you can plan that you won't see the same growth rates in those metrics that we've seen, in in q two just given the pullback in promotion, but really excited, for what we see underneath that promotion on our business as usual days.

John Kernan
Managing Director at TD Cowen

Got it. And then maybe just a follow-up on selling expenses. Obviously, really nice leverage this quarter, 300 basis points. There's still a ways to go to get back to that twenty twenty three kind of selling expense as a percent of sales. Just curious how you're thinking about the leverage on that line item into the back half of the year?

John Kernan
Managing Director at TD Cowen

And is there a specific time frame when you think it's reasonable to get back to that 22.9 that you generated in for the full year that you generated in 2023?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. So, really excited with the progress that we've made in this area. The progress has come faster than what we expected given that we've really ramped up our ramped up our efforts there, and have been really great at delivering on that. So we've seen some of those savings both within shipping and within fulfillment, and we'll continue to realize the benefits that we're seeing, and continue through with what has been realized. So these are sustainable savings because they come as a result of actions that we've taken that will be, you know, permanent, over time.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And so we're feeling increasingly confident that we will be able to return our selling rates back down to that, 2023 level, you know, by next year. So we're well on our way and, excited that we're gonna get there faster than what we had originally thought.

John Kernan
Managing Director at TD Cowen

Okay. And then just one follow-up on that. The revenue growth will be a little bit slower in the back half. Does that does that imply there'll be a little bit less leverage on the selling line?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. That's correct. From what you've seen.

John Kernan
Managing Director at TD Cowen

Okay.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. That's correct. Yep.

John Kernan
Managing Director at TD Cowen

Okay. Got it. Thank you.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Thank you.

Operator

The next question is from the line of Ashley Owens with KeyBanc Capital Markets. You may proceed.

Christopher Brazeau
Christopher Brazeau
Equity Research Associate at KeyBanc Capital Markets

Hey guys, this is Chris on for Ashley. Thanks for taking our question. So I wanted to talk about I mean, it's great to see the growth in scrub wear this quarter. I'm wondering if you could just expand a little bit on the softness in non scrub wear and maybe if we can expect any rebound from apparel or lifestyle launches in 3Q?

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Sure. Thanks, Chris. You know, in terms of non scrub wear, there is some noise in the quarter. We did have less non scrubware launches in q two. And so, you know, when you're looking over any ninety day period, there's gonna be some noise.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

But when you zoom out, our stacked three year growth rate on non scrubware is 35%. So we know, you know, non scrubs is a healthy business that health care professionals love. We are a lifestyle brand, outfitting health care professionals to work, at work, from work, on shift, off shift, head to toe. And so, you know, we're gonna continue to really be the brand for them throughout their life. And we we also know there's really a a huge opportunity to go even deeper.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

That's just one example. You know, if you if you look at our underscrub business, you know, it really is one fabrication, the Salta underscrub for women, the Makoto underscrub for men. And so there's much more that we're excited to build out here. And without giving away, our plans, you know, that's not just it's not just within underscrubs. It's within footwear, within outerwear, within, actually, our compression sock business.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We're expanding into more franchises, and, you know, we're excited to kinda keep building the portfolio and really giving our health care professionals more of what they love.

Christopher Brazeau
Christopher Brazeau
Equity Research Associate at KeyBanc Capital Markets

Okay. Great. And then just one follow-up on share repurchases. So obviously, none this quarter. But I'm just kind of wondering maybe as we move throughout the rest of the year, like how you're balancing choosing to repurchase versus maybe growth initiatives and, you know, if there's any areas you're looking to be more opportunistic.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. So as we we said in our remarks at this time, you know, we're focusing on deploying our capital and prioritizing that towards growing the business. We've we've set out on that this year, and we've been really successful so far as you can see from our results. So we know that that investment is working for us. And, you know, we're gonna preserve our balance sheet just given some of the uncertainty.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

That said, we will continue to be opportunistic, but we will be more conservative given where we were at previously.

Christopher Brazeau
Christopher Brazeau
Equity Research Associate at KeyBanc Capital Markets

Okay. Great. Thanks, guys. I'll pass it on.

Operator

The next question is from the line of Brian Nagel with Oppenheimer. You may proceed.

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

Hey, good afternoon. Congrats on the continued progress here. Nice quarter.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Thanks,

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

Brian. The question I want I guess my first question, a little bit longer term, as the business is recovering here, we've started to see this clear now over the last few or even several quarters. I guess how should we think about the what's a what should be a healthy growth rate, top line growth rate for Figs? And then within the context of that, to get there, what still needs to happen? We we know we like I said, we've seen the business start to recover here, but still not work.

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

You know, maybe we're so where where can we get you and what has to happen to get it there?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. So we're we're not gonna give any guidance at this point on specifically what our growth rate is gonna be, but I think, you know, we're pretty clear on what our our growth our growth algorithm is. And first part of that was really returning our core business to growth. And so we're on our way to do that as you can see with some of the results that we've, you know, produced in terms of our US business returning to growth, reinvigorating the growth within our new customers as well, and and and scrub wear as well. So we're on our way there, and there's more room for us to continue to grow within the core of our business.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

You know? And then we have our opportunities within our growth drivers, within teams, international, and our retail hub. And so we've set out what those strategies are, and we're still early in in those avenues. And so we'll see that, I think, ramp up more so in 2026 and onwards. And, you know, we're seeing good proof points that what we're doing to drive growth there is working.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And, you know, we'll need to continue to invest in building out, you know, the the resources, the people, the capabilities behind those. And we've, you know, we've been doing that already, and it's working. So we will continue to do that and and look forward to, you know, continuing to drive growth in the business going forward.

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

That's helpful. I appreciate it. And my follow-up question is on tariffs. Look, recognizing FIGs is unique, there's really not much in the way of direct competition. But the question I'd ask is, seem like your strategy towards tariffs is solidified nicely.

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

Are you seeing tariffs cause any type of disruptions within your competitive set, either positively or negatively for FIGs?

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

No. I think you know how I feel about this question, Brian. We try not to look left or right. We're really focused on our own business and continuing to lead the industry from a product standpoint, from a marketing standpoint, from an execution, customer experience standpoint. But you can, you know, do some digging, and you'll see that we're pretty well positioned in the space.

Brian Nagel
MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.

Got it. No, I appreciate that. Thank you. Congrats again.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Thank you.

Operator

The next question is from the line of Matt Corrondo with Roth Capital. You may proceed. Matt, your line may be muted.

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

Sorry about that, guys. Can you hear me now?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yep. You're good.

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

Okay. Perfect. Sorry about that. So I guess I was wanting to take a look at the sales progression in the second quarter. It looks like the growth came in quite a fair bit ahead of the flattish guide that you gave for the quarter.

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

So maybe just wanted to hear about how the quarter progressed in May and June, just any comments you have on July and how that sort of fits into the the second half guide that implies kind of flattish, sales.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. Definitely. So, you know, our guide is flat on the quarter was really reflecting that we were comping over a strong period of growth last year, that was driven by newness. And, you know, we did say that the flow of product launches this quarter would be a little lighter relative to other quarters. And we were just being prudently cautious amid the current environment.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And, you know, what what we've seen is we were able to overcome all of those headwinds. Seeing really great overall growth in our, you know, baseline business as usual days. And, you know, we we saw progress towards the end of the quarter as it was related to some of our color launches and newness and, you know, really seeing all the things that Trina had spoken about earlier that's really supporting our product and marketing really start to turn on. And so as we enter into q three, we're seeing, you know, the trends from q two continue. But keep in mind that q three will have a much bigger impact from the pullback in promo than what we saw in q two.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

So so while those trends are there, there's gonna be a larger headwind into q three, and that's why our guide of zero to 2% is lower than where we were where we finished off in q two.

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

Okay. And then maybe just a little bit more on on the pullback in promos in the second half. Can you talk about, like, how that shows up? Is it sort of less sample sales and sitewide promos? Is it sort of the same number of promotional events with shorter duration?

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

Is it lower depth of discount? Like, what's the right way to think about sort of the posture there?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. I mean, it's really all of the above. And so we we've really shifted to have our site wide promos be more specific to events that celebrate health care professionals. So for example, in the second quarter, we still did our nurses week promo. In q one, we still did match day.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And right now, you know, we're doing our our back to school, which is is large for health care workers as well. And so we have pulled back on some of the site wide promos that, you know, are were more generic in the past. We've also taken the time to shift some of these promos to be more sample sale focused. So clearing out older inventory rather than the site wide off of everything. So we're just being more strategic with the way that we're delivering it, the timing, and the length.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

So, you know, there's there's a a broad variety of shifts that we are making in each of our quarters this year.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And the only thing I would add to that is just, you know, the the reason we're able to pull back is because our baseline days are really strong. And, you know, and that's why, you know, we really feel great about the health of the business over the long run, protecting the brand, ensuring that, you know, we are doing everything we can to deliver the best product and engage our community in meaningful ways. And so really feel good about the long term health of the business.

Matthew Koranda
MD & Senior Research Analyst at Roth Capital Partners, LLC

Okay. Super helpful. I'll leave it there. Thanks.

Operator

Next question is from the line of Rick Patel with Raymond James. You may proceed.

Rick Patel
Rick Patel
Managing Director at Raymond James Financial

Good afternoon and congrats on strong execution. I did have a question on inventory. So did it reflect any pull forward given the uptick in costs related to tariffs? And I think you touched on investing in certain areas of the business as well. Just some additional color would be there on inventory.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Sure. Thanks, Rick. So our inventory was up 14% on a dollar basis. A portion of that is due to tariffs related to receipts that came up. If you look at it on a unit basis, we are up 8%.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

So the differential is really from a mix shift in the cost base towards higher cost goods. You can think about that as some of our higher cost scrub wear as well as outerwear and shoes as an example. And then once you look at that 8% growth in units, yeah, that is definitely being driven by in transit as we did pre position some inventory to get ahead of the original tariff date. So some of that is pull forward.

Rick Patel
Rick Patel
Managing Director at Raymond James Financial

Got it. And then can you just help us understand the international growth rate? How much did you benefit from FX in the quarter? And what kind of currency benefit do you have baked in for the back half?

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yes. So we haven't shared the specific impact of FX, although it was not a material impact. So keep in mind that international is 15% of our business, so it wouldn't be a large impact on overall growth rates. We're really excited with where international finished at a 20% growth rate on the quarter, which was up from 16% that we delivered in Q1. International is still at 15% of the business and really seeing good growth rates and that growth coming from Mexico, Europe, Middle East, and Latin America.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

And that is really healthy growth coming from both new customer acquisition as well as returning customers. So, you know, really happy with the progress that we're seeing as broad based growth across many regions and across many different customer metrics in international.

Rick Patel
Rick Patel
Managing Director at Raymond James Financial

Thanks very much.

Operator

Final question comes from the line of Nathan Feather with Morgan Stanley. You may proceed.

Nathan Feather
Nathan Feather
Equity Research Associate at Morgan Stanley

Hey, everyone, and thanks for taking the question. You noticed some macro headwinds implied in the full year guide. I just wanted to get a sense of what you're building in across the range in 3Q and the full year. Then is there something you're seeing recently that causes you to build on that or or more just being prudent given the volatility we've seen here today? Thanks.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

Yeah. So I would say that the majority of the pullback in growth rates in two h versus where we have performed in one h is due to the expectation of a larger impact from pullback in promo. So that's really the greatest piece of it. And I would say that, you know, our our revenue guide, you know, accommodates for various different scenarios. And there, you know, there is some you know, we are being prudent.

Sarah Oughtred
Sarah Oughtred
CFO at FIGS

The environment is still, you know, uncertain. So, you know, we feel like that we are giving appropriate guidance based on on what we see in our business right now.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And I would just add, you know, from a macro standpoint, health care jobs are growing three times faster than the overall job market. And there's been, as you know, a long running staffing shortage within health care, doctors, nurses, etcetera. So the demand for health care professionals is really high. We've also talked about this COVID overhang and, you know, the the idea that health care professionals stocked up, right, during the pandemic, and that caused them to slow their purchasing behavior. Fortunately, we're continuing to see signs that we're getting further away from the pandemic and that overhang is easing, and we're entering a more normalized purchasing environment.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

And so in some of the metrics that we're looking at that is showing this shift, we talked about AOV growth, almost matching our record quarter last quarter. We're seeing acquisition trends, you know, trending positively. We're seeing customers are coming back to us, and we're seeing accelerated growth in The US, in scrubware, and in ecommerce. So this gives us a really, a lot of reasons to believe that we're starting to operate in a more normalized environment, that, our the health of our customer health care professionals, is really strong, and and, we're really hopeful about the future, of our community and of our business.

Nathan Feather
Nathan Feather
Equity Research Associate at Morgan Stanley

Great. That's really helpful. And then I just wanna let you know. Excited to see, community hub rollout expand in 4Q. Just to get a sense, I know you've been in a little bit of a test and learn phase with the first two community hubs. Given the expansions here, is it kind of just an expansion of that test, or should we expect maybe a more consistent increase of community hubs as we go into '26 and '27 as you start to lock down the operating model?

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

We are opening more community hubs. So we talked about Houston is coming. We just announced for the first time ever, New York City and Chicago are coming, and much more to come. So we're really excited by being in person with our community. We continue to see nearly 40% of our customers in our community hubs are new to the brand.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

30% of those acquired customers are coming back and becoming omnichannel customers shopping online. And so it's really exciting. We're seeing really strong incrementality in the markets that we're in, and we're excited. We're excited to go to more markets, go to more cities, engage both online and off line. We're really learning what's working for us in terms of format, location, how close to health care institutions, being, you know, close by the best, largest health care institutions in the country.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

So, you know, couldn't be more excited about where we're going. We've also learned a lot in terms of, you know, the design, and and we're making, a lot of tweaks to future to future community hubs. So it's a very exciting time, and thank you for the question.

Operator

That was our last question, so I would now like to pass the conference back for any closing remarks.

Trina Spear
Trina Spear
Co-Founder, CEO & Board Member at FIGS

Thank you all for joining us. It was a great quarter, and we look forward to seeing you next time.

Operator

That concludes today's call. Thank you for your participation, and enjoy the rest of your day.

Executives
    • Tom Shaw
      Tom Shaw
      SVP of Investor Relations
    • Trina Spear
      Trina Spear
      Co-Founder, CEO & Board Member
    • Sarah Oughtred
      Sarah Oughtred
      CFO
Analysts
    • Angus Kelleher-Ferguson
      Equity Research Associate at Barclays Corporate & Investment Bank
    • Dana Telsey
      CEO & Chief Research Officer at Telsey Advisory Group
    • Brooke Roach
      VP - Equity Research at Goldman Sachs
    • John Kernan
      Managing Director at TD Cowen
    • Christopher Brazeau
      Equity Research Associate at KeyBanc Capital Markets
    • Brian Nagel
      MD & Senior Analyst - Consumer Growth & eCommerce at Oppenheimer & Co. Inc.
    • Matthew Koranda
      MD & Senior Research Analyst at Roth Capital Partners, LLC
    • Rick Patel
      Managing Director at Raymond James Financial
    • Nathan Feather
      Equity Research Associate at Morgan Stanley
Powered by Quartr